Annual Report and Accounts Posted to Shareholders

6th June 2018 - 7:00 am

Notice of Annual general Meeting on 28 June 2018 @ 10.30 AM

Venue: Sky Light City Tower, 50 Basinghall Street, London, EC2

ImmuPharma PLC (LSE:IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2017 has been posted to shareholders.

This report includes the ‘Annual Report of the Annual General Meeting’ (‘AGM’) as well as the ‘Notice of the 2018 AGM’, which will be available later today, in electronic form, for download on the Company’s website

ImmuPharma’s AGM will be held on Thursday 28 June at 10:30am at Sky Light City Tower, 50 Basinghall Street, EC2V 5DE.

Share this article